Stereotaxis STXS
NYSE STXS
$0.83 -0.02 (-2.35%)
At close: Nov 13, 2026 · 4:00 PM EST

Stereotaxis (STXS) Gains from Sales and Divestitures (2009 - 2018)

Updated

Stereotaxis' Gains from Sales and Divestitures was -$170.00 in FY2021.

Analysis

Stereotaxis (STXS) Gains from Sales and Divestitures (2009 - 2018) Analysis & Trends

From FY2009 onward, Stereotaxis has reported Gains from Sales and Divestitures for 9 years.

  • The FY2021 figure marks the highest annual Gains from Sales and Divestitures since FY2009.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier years was -$94,931 in FY2018 and -$98,550 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Stereotaxis 83.17 Mn 83.17 Mn 3.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -93,482.00
Dec 31, 2017 -77,778.00
Jun 30, 2017 -6,174.00
Mar 31, 2017 -14,598.00
Dec 31, 2013 -19,217.00
Sep 30, 2013 -9,513.00
Dec 31, 2012 -8,322.00
Dec 31, 2011 -169,983.00
Sep 30, 2011 83,705.00
Dec 31, 2010 -10,078.00
Sep 30, 2010 483.00
Mar 31, 2010 4,556.00
Dec 31, 2009 5,593.00
Jun 30, 2009 539,122.00
Mar 31, 2009 12,437.00
API Access

Stereotaxis Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=STXS&period=max&api_key=YOUR_API_KEY